ZH
RU
ES

Biopharmaceuticals

Biopharmaceuticals, Total:57 items.

In the international standard classification, Biopharmaceuticals involves: Water quality, Microbiology, Animal feeding stuffs, Vocabularies.

RU-GOST R, Biopharmaceuticals

• GOST R 57688-2017 Medicines for medical applications. Stability testing of biotechnological/biological medications
• GOST 31928-2013 Probiotics medicine remedies for veterinary use. Methods for determination of the probiotics microorganisms
• GOST R 55291-2012 Probiotic medicine remedies for veterinary use. Methods of microbiological analysis

Professional Standard - Agriculture, Biopharmaceuticals

• 1773药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Neonates 2. Calculation of Drug Dose in Neonates
• 1772药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Newborns 1. Pharmacokinetic characteristics of newborns
• 1032药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Erlotinib
• 1031药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Gefitinib
• 1033药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sunitinib
• 1034药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Ubenimex
• 1028药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sorafenib
• 1030药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Lapatinib
• 1029药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Imatinib
• 1027药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Bevacizumab
• 1025药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Rituximab
• 1023药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Trastuzumab
• 1024药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Nimotuzumab
• 1026药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Cetuximab
• 1022药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Recombinant Human Interleukin-2
• 1325药典 化学药和生物制品卷-2010 Chapter 18 Biological Products V. Thrombolytic Drug Streptokinase
• 1326药典 化学药和生物制品卷-2010 Chapter 18 Biological Products V. Thrombolytic Drug Urokinase
• 1681药典 化学药和生物制品卷-2010 Chapter 26 Ophthalmic Drugs Section 10 Biological Products and Biochemical Drugs Recombinant Human Interferon a1b
• 1775药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application for Newborns 4. Common Drugs for Neonatal Resuscitation and Reference Doses of Commonly Used Antibiotics
• 1680药典 化学药和生物制品卷-2010 Chapter 26 Ophthalmic Drugs Section 10 Biological Products and Biochemical Drugs Recombinant Bovine Basic Fibroblast Growth Factor
• 1327药典 化学药和生物制品卷-2010 Chapter 18 Biological Products V. Thrombolytic Drug Alteplase
• 1329药典 化学药和生物制品卷-2010 Chapter 18 Biological Products V. Thrombolytic Drug Reteplase*
• 1328药典 化学药和生物制品卷-2010 Chapter 18 Biological Products V. Thrombolytic Drug Tenecteplase*
• 1774药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Neonates 3. Precautions for Antibiotics Use in Neonates
• 1021药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drugs Recombinant Human Granulocyte Macrophage Stimulating Factor
• 1201药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 3 Parenteral Nutritional Drugs III. Carbohydrates
• 1398药典 化学药和生物制品卷-2010 Chapter 20 Antidote Section 2 Specific Antidote VI. Drug Poisoning Antidote Vitamin B6*
• 1150药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1. Single-dose vitamin D3
• 1138药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1. Single-dose Vitamin A
• 1148药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1. Single-dose Vitamin C
• 1144药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1. Single-dose vitamin B12
• 1141药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1, Single-dose Vitamin B2
• 1140药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1, Single-dose Vitamin B1
• 1142药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1, Single-dose Vitamin B6
• 1149药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1, Single-dose Vitamin D
• 1156药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Medicines Section 1 Vitamin 1. Single-dose Vitamin K
• 1155药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1, Single-dose Vitamin E
• 1157药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1, Single-dose Vitamin K1
• 1159药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 2, Mixture Vitamin AD
• 555药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Drugs Section Three Urinary System Special Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (3) Natural herbal medicine Pygeum africanum extract*
• 1158药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 2, Vitamin B Mixtures
• 638药典 化学药和生物制品卷-2010 Chapter IX Endocrine System Drugs Section 1 Hypothalamic-Pituitary Hormones and Related Drugs 4. Growth Hormone Growth Hormone
• 852药典 化学药和生物制品卷-2010 Chapter 10 Anti-infective Drugs Section 10 Other Antibiotics Fosfomycin
• 2409药典 二部-2010 Appendix XIX B Guidelines for human bioavailability and bioequivalence testing of pharmaceutical preparations
• 358药典 化学药和生物制品卷-2010 Chapter 4 Cardiovascular System Drugs Section 7 Bosentan Drugs for Reducing Pulmonary Arterial Hypertension
• 554药典 化学药和生物制品卷-2010 Chapter 7 Urinary System Drugs Section 3 Special Urinary System Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (3) Natural herbal medicine Pushitai Tablets
• 853药典 化学药和生物制品卷-2010 Chapter 10 Anti-infective Drugs Section 10 Other Antibiotics Linezolid
• 854药典 化学药和生物制品卷-2010 Chapter 10 Anti-infective Drugs Section 10 Other Antibiotics Fusidic Acid
• 1172药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 2 Minerals and Trace Elements Iodides
• 1146药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1. Single-dose Niacin
• 1145药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals, and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 1. Single-dose folic acid
• 1161药典 化学药和生物制品卷-2010 Chapter 15 Vitamins, Minerals and Parenteral and Enteral Nutritional Drugs Section 1 Vitamin 2, Water-soluble Vitamins for Mixture Injection

CZ-CSN, Biopharmaceuticals

• CSN ON 65 5758-1966 Biological Testing of Pesticides. Determination of Biological Activity oí Seed Dressings.

American Society for Testing and Materials (ASTM), Biopharmaceuticals

• ASTM E2363-23 Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry

Others:   Medicinal biology, biological drug, Medicinal microorganism, Biological tooth, Biopharmaceuticals, biodegradable, Biological contamination, bio-based organisms, biological drug, Agricultural Biopharmaceuticals, biological biofiltration, Chemical and Biological Drugs, biological biological container, Frontiers of Biopharmaceuticals, Class II Biological Drugs, Biological medicine, Biopharmaceuticals, Upstream biopharmaceuticals, Biopharmaceutical Thirteenth Five-Year Plan, Biological Class III Drugs.